829 related articles for article (PubMed ID: 18271058)
1. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy.
Zheng YG; Wu J; Chen Z; Goodman M
Med Res Rev; 2008 Sep; 28(5):645-87. PubMed ID: 18271058
[TBL] [Abstract][Full Text] [Related]
2. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
[TBL] [Abstract][Full Text] [Related]
3. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
[TBL] [Abstract][Full Text] [Related]
4. The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.
Bronner C; Chataigneau T; Schini-Kerth VB; Landry Y
Curr Med Chem; 2007; 14(25):2629-41. PubMed ID: 17979715
[TBL] [Abstract][Full Text] [Related]
5. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
An W
Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
[TBL] [Abstract][Full Text] [Related]
6. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer.
Sundar IK; Rahman I
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1245-L1258. PubMed ID: 27793800
[TBL] [Abstract][Full Text] [Related]
8. Histone modification therapy of cancer.
Biancotto C; Frigè G; Minucci S
Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
[TBL] [Abstract][Full Text] [Related]
9. Regulation of histone modifying enzymes by the ubiquitin-proteasome system.
Zou C; Mallampalli RK
Biochim Biophys Acta; 2014 Apr; 1843(4):694-702. PubMed ID: 24389248
[TBL] [Abstract][Full Text] [Related]
10. Small molecule control of chromatin remodeling.
Finley A; Copeland RA
Chem Biol; 2014 Sep; 21(9):1196-210. PubMed ID: 25237863
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
12. Histone acetylation in gene regulation.
Verdone L; Agricola E; Caserta M; Di Mauro E
Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467
[TBL] [Abstract][Full Text] [Related]
13. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
14. Histone modifications and cancer.
Sawan C; Herceg Z
Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
[TBL] [Abstract][Full Text] [Related]
15. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
16. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z; Ramazi S; Allahverdi A
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
[TBL] [Abstract][Full Text] [Related]
17. Effect of non-enzymatic glycosylation in the epigenetics of cancer.
Rehman S; Aatif M; Rafi Z; Khan MY; Shahab U; Ahmad S; Farhan M
Semin Cancer Biol; 2022 Aug; 83():543-555. PubMed ID: 33276090
[TBL] [Abstract][Full Text] [Related]
18. Targeting epigenetic regulations in cancer.
Ning B; Li W; Zhao W; Wang R
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):97-109. PubMed ID: 26508480
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
